Immunogenicity 11911

summary
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CD5L
Transcript ID
uc001frk.4
HLA INFO
C*12:03
TCR INFO

No TCR info found!

T cell Tumor cell C*12:03
sequence
Full length protein sequence (347 aa)
MALLF
1
SLILA
6
ICTRP
11
GFLAS
16
PSGVR
21
LVGGL
26
HRCEG
31
RVEVE
36
QKGQW
41
GTVCD
46
DGWDI
51
KDVAV
56
LCREL
61
GCGAA
66
SGTPS
71
GILYE
76
PPAEK
81
EQKVL
86
IQSVS
91
CTGTE
96
DTLAQ
101
CEQEE
106
VYDCS
111
HDEDA
116
GASCE
121
NPESS
126
FSPVP
131
EGVRL
136
ADGPG
141
HCKGR
146
VEVKH
151
QNQWY
156
TVCQT
161
GWSLR
166
AAKVV
171
CRQLG
176
CGRAV
181
LTQKR
186
CNKHA
191
YGRKP
196
IWLSQ
201
MSCSG
206
REATL
211
QDCPS
216
GPWGK
221
NTCNH
226
DEDTW
231
VECED
236
PFDLR
241
LVGGD
246
NLCSG
251
RLEVL
256
HKGVW
261
GSVCD
266
DNWGE
271
KEDQV
276
VCKQL
281
GCGKS
286
LSPSF
291
RDRKC
296
YGPGV
301
GRIWL
306
DNVRC
311
SGEEQ
316
SLEQC
321
QHRFW
326
GFHDC
331
THQED
336
VAVIC
341
SG
346
Mutation Information
DNA mutation:
None
Peptide Range:
229 ~ 253
Mut AA position:
241 (13 in Wild Type peptide)
Alignment
Wild Type:
"NHDEDTWVECEDPFDLRLVGGDNLC
||||||||||||.||||||||||||
Mutant:
NHDEDTWVECEDSFDLRLVGGDNLC"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

PBMCs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay